Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | GlycoMimetics Inc | Equity | 38000Q102 | 548 | 481 | SH | DFND | 1 | 0 | 481 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0001398344-22-009797 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | CAROLINAS WEALTH CONSULTING LLC | 1803425 | GLYCOMIMETICS INC | COM | 38000Q102 | 0 | 395 | SH | SOLE | 0 | 0 | 395 | May 18th, 2022 01:12AM | May 18th, 2022 01:12AM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0001697013-22-000003 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Eversept Partners, LP | 1697013 | GLYCOMIMETICS INC | COM | 38000Q102 | 115 | 100579 | SH | SOLE | 100579 | 0 | 0 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0001677253-22-000002 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Intellectus Partners, LLC | 1677253 | Glycomimetics Inc | Common Stock | 38000Q102 | 103 | 90500 | SH | SOLE | 0 | 0 | 90500 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | ||
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0000895421-21-000453 | Jun 30th, 2021 12:00AM | Aug 16th, 2021 12:00AM | Aug 16th, 2021 12:00AM | MORGAN STANLEY | 895421 | GLYCOMIMETICS INC | COM | 38000Q102 | 1 | 320 | SH | DFND | 07 | 0 | 320 | 0 | May 4th, 2022 10:32PM | May 4th, 2022 10:32PM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0000895421-21-000453 | Jun 30th, 2021 12:00AM | Aug 16th, 2021 12:00AM | Aug 16th, 2021 12:00AM | MORGAN STANLEY | 895421 | GLYCOMIMETICS INC | COM | 38000Q102 | 100 | 42943 | SH | DFND | 04 | 42943 | 0 | 0 | May 4th, 2022 10:32PM | May 4th, 2022 10:32PM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0000895421-21-000453 | Jun 30th, 2021 12:00AM | Aug 16th, 2021 12:00AM | Aug 16th, 2021 12:00AM | MORGAN STANLEY | 895421 | GLYCOMIMETICS INC | COM | 38000Q102 | 0 | 182 | SH | DFND | 02 | 182 | 0 | 0 | May 4th, 2022 10:32PM | May 4th, 2022 10:32PM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0000895421-21-000453 | Jun 30th, 2021 12:00AM | Aug 16th, 2021 12:00AM | Aug 16th, 2021 12:00AM | MORGAN STANLEY | 895421 | GLYCOMIMETICS INC | COM | 38000Q102 | 2 | 969 | SH | DFND | 01 | 969 | 0 | 0 | May 4th, 2022 10:32PM | May 4th, 2022 10:32PM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0000093751-21-000640 | Jun 30th, 2021 12:00AM | Aug 16th, 2021 12:00AM | Aug 16th, 2021 12:00AM | STATE STREET CORP | 93751 | GLYCOMIMETICS INC | COM | 38000Q102 | 335 | 144265 | SH | DFND | 20 | 144265 | 0 | 0 | May 4th, 2022 10:30PM | May 4th, 2022 10:30PM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology | |
nasdaq:glyc | nasdaq:glyc Shareholders | 13F-HR | 0000072971-21-000287 | Jun 30th, 2021 12:00AM | Aug 16th, 2021 12:00AM | Aug 16th, 2021 12:00AM | WELLS FARGO & COMPANY/MN | 72971 | GLYCOMIMETICS INC | COM | 38000Q102 | 0 | 40 | SH | DFND | 3 | 40 | 0 | 0 | May 4th, 2022 10:30PM | May 4th, 2022 10:30PM | GlycoMimetics | Health Care | Pharmaceuticals & Biotechnology |